A molecular, enzymatic and clinical study in a family with hereditary coproporphyria-Reference-Cited by-同舟云学术

A molecular, enzymatic and clinical study in a family with hereditary coproporphyria

Published:2002-06 Issue:4 Volume:25 Page:279-286
ISSN:0141-8955
Container-title:Journal of Inherited Metabolic Disease
language:en
Short-container-title:J Inherit Metab Dis

Author:

Gross U.¹,Puy H.²,Meissauer U.¹,Lamoril J.²,Deybach J. C.²,Doss M.¹,Nordmann Y.²,Doss M. O.¹³

Affiliation:

1. ; Division of Clinical Biochemistry; Philipps University Hospital; Marburg Germany

2. ; Centre Français des Porphyries, INSERM U409; Hôpital Louis Mourier; Colombes France

3. Division of Clinical Biochemistry; Postfach 12 20 Marburg 35002 Germany

Publisher

Wiley

Subject

Genetics (clinical),Genetics

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1023/A:1016598207397/fullpdf

Reference13 articles.

1. B. Porphyrins and Porphyrin Precursors

2. Relationships between acute hepatic porphyrias due to genetic variability of primary enzyme defects and limiting function of uroporphyrinogen synthase;Doss;Int J Biochem,1978

3. Heredit Pre Koproporphyrie in der Bundesrepublik Deutschland;Doss;J Clin Chem Clin Biochem,1978

4. ‘Glucose effect’ and rate limiting function of uroporphyrinogen synthase on porphyrin metabolism in hepatocyte culture: relationship with human acute hepatic porphyrias;Doss;J Clin Chem Clin Biochem,1985

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute hepatic porphyrias: Recommendations for diagnosis and management with real-world examples;Molecular Genetics and Metabolism;2023-11

2. Psychiatric disorders secondary to neurometabolic disorders;Revista Colombiana de Psiquiatría (English ed.);2018-10

3. Trastornos psiquiátricos secundarios a enfermedades neurometabólicas;Revista Colombiana de Psiquiatría;2018-10

4. Maladies neurométaboliques. Un nouveau champ d’intérêt pour la psychiatrie de l’enfant et de l’adolescent;Neuropsychiatrie de l'Enfance et de l'Adolescence;2017-03

5. Maladies neurométaboliques traitables associées aux troubles du spectre de la schizophrénie;La Presse Médicale;2015-09